Item 1.01 Entry into a Material Definitive Agreement.

On October 27, 2021, Silicon Laboratories Inc. ("Silicon Laboratories" or the "Company") entered into a confirmation, including a supplemental confirmation (collectively, the "ASR Agreement") of an accelerated share repurchase transaction with Goldman Sachs & Co. LLC (the "Dealer"). Under the ASR Agreement, the Company shall repurchase an aggregate of $400 million of Silicon Laboratories' common stock as part of its previously announced share repurchase program. Matthews South, LLC acted as structuring adviser to the Company on the ASR Agreement.

Under the terms of the ASR Agreement, the Company will receive an aggregate initial share delivery of approximately 1.739 million shares from the Dealer, with the remaining shares, if any, expected to be delivered by the Company's first fiscal quarter of 2022. The specific number of shares that the Company will ultimately repurchase under the ASR Agreement will be based on the terms and conditions of the ASR Agreement, including the average of Rule 10b-18 daily volume-weighted average share prices of the Company's common stock during the trading period, less a discount. At settlement of the ASR Agreement, the Dealer may be required to deliver additional shares of common stock to the Company, or, under certain circumstances, the Company may elect to make a cash payment or deliver shares of common stock to the Dealer.

The above description of the ASR Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the ASR Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits





(d) Exhibits.



  10.1     ASR Agreement dated October 27, 2021 between Silicon Laboratories Inc.
         and Goldman Sachs & Co. LLC

104      Cover Page Interactive Data File (formatted as Inline XBRL and contained
         in Exhibit 101)

© Edgar Online, source Glimpses